nir-vana innovation network

The Russian manufacturer of pharmaceuticals from St. Petersburg was founded in 1999. Over the years of its existence in the market of medical devices, the company has become a leader in the production of medical products in Russia. The company produces dry and liquid concentrates for bicarbonate and acetate hemodialysis.
The company manufacturers: sets of dry salts for the preparation of a concentrated dialysis fluid solution, concentrated dialysis fluid solutions for bicarbonate hemodialysis, concentrated dialysis fluid solutions for acetate hemodialysis, bicarbonate cartridges, concentrated hemodialysis solution with succinic acid, totally colorless dialysis fluid solutions, dialysis equipment.
Dry concentrates are available in sets for the preparation of 25, 50, and 100 liters of liquid concentrate. There are 3 types of concentrates available: acid, bicarbonate, and acetate. Liquid concentrates are available in 5.5 l packages, 5 and 10L cans, 250L tanks (for centralized concentrate distribution systems). The company produces concentrates with the widest range of glucose levels from 0.5, 1.0, and 2.0 g/l. The product also includes salts of the following components: sodium, potassium, magnesium, calcium, and anions of weak acids.
These products are used in the hemodialysis system to remove the end products of metabolism from the blood and to maintain the appropriate concentration of electrolytes in the blood and the pH level. Thanks to the use of this product, it helps patients to stabilize the function of the cardiovascular system, normalizes the antioxidant status of the body, reduces the manifestations of endothelial dysfunction, and reduces the level of systemic inflammation.
Today, the company has 1700 m2 of its own production space and more than 2000 m2 of its own warehouse space, which is equipped with special refrigerators and equipment, where raw materials and finished products are stored. All raw materials used in the manufacturing process comply with the European pharmacopeia, ISO standards and are inspected in the company's own laboratory. The production is certified according to international and Russian standards.
The company's partners are state medical and preventive institutions and laboratories, commercial clinics, research institutes, sanatoriums, veterinary clinics.
The company is interested in finding partners from the sphere of wholesale and retail trade of pharmaceuticals and medical components to conclude a distribution services agreement. The Russian company is ready to organize the transportation of the products to the partners. In the framework of the agreement the company will deliver the products to the partner and will organize the sales and marketing processes in the European markets. As a result of cooperation, the Russian company wishes to expand into the European foreign market and seeks partners in the countries of interest in order to conclude a distribution service agreement.

Advantages & innovations

- In production, the company has strict quality control in several stages. All raw materials that are purchased from European manufacturers pass their own laboratory tests. After that, each batch of solutions produced once again passes quality control and compliance with all the declared characteristics and functions. - The company successfully operates not only on the Russian market but also on the market of CIS countries. All company’s products are certified according to international standards. The company has patents for its inventions. The company participates in international conferences and exhibitions, for example - The International Exhibition on Intensive Care and Emergency Medicine.

Stage of development

Already on the market

Partner sought

Type: SMEs, large companies Role: a partner from the sphere of wholesale and retail trade of pharmaceuticals and medical components will be engaged in the distribution of Russian products on the foreign market.